Compare CERS & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CERS | TIPT |
|---|---|---|
| Founded | 1991 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Property-Casualty Insurers |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 585.1M | 663.9M |
| IPO Year | 1996 | 2017 |
| Metric | CERS | TIPT |
|---|---|---|
| Price | $3.12 | $18.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 246.7K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 1.40% |
| EPS Growth | ★ 27.27 | N/A |
| EPS | N/A | ★ 0.34 |
| Revenue | ★ $51,326,000.00 | $488,000.00 |
| Revenue This Year | $19.95 | N/A |
| Revenue Next Year | $8.84 | N/A |
| P/E Ratio | ★ N/A | $53.53 |
| Revenue Growth | ★ 30.68 | N/A |
| 52 Week Low | $1.15 | $15.49 |
| 52 Week High | $3.21 | $27.38 |
| Indicator | CERS | TIPT |
|---|---|---|
| Relative Strength Index (RSI) | 69.04 | 60.15 |
| Support Level | $2.37 | $18.11 |
| Resistance Level | N/A | $18.83 |
| Average True Range (ATR) | 0.17 | 0.45 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 94.34 | 64.24 |
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.